Removing a patient’s tumor while sparing healthy tissue requires exquisite precision, but often surgeons must rely on their eyes and hands to determine where to cut.
Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
October 16, 2024